{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:10:05Z","timestamp":1784257805388,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"DOI":"10.1007\/s11481-024-10168-0","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T05:09:34Z","timestamp":1736831374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["LncRNA NEAT1, an Important Biomarker Involved in the Pathological and Physiological Processes of Parkinson's Disease"],"prefix":"10.1007","volume":"20","author":[{"given":"Runsen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kede","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuming","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaocong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"issue":"2","key":"10168_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1042\/bj3480241","volume":"348","author":"AL Bishop","year":"2000","unstructured":"Bishop AL, Hall A (2000) Rho GTPases and their effector proteins. Biochem J 348(2):241\u2013255","journal-title":"Biochem J"},{"issue":"1","key":"10168_CR2","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadi\u00e8re B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, Bonduelle O, Alvarez-Fischer D, Callebert J, Launay JM, Duyckaerts C (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119(1):182\u2013192","journal-title":"J Clin Invest"},{"issue":"1","key":"10168_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.biochem.74.082803.133400","volume":"74","author":"MR Cookson","year":"2005","unstructured":"Cookson MR (2005) The biochemistry of Parkinson\u2019s disease. Annu Rev Biochem 74(1):29\u201352","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"10168_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/ejn.13132","volume":"43","author":"Q He","year":"2016","unstructured":"He Q, Li Y, Guo S, Wang Y, Lin W, Zhang Q, CungenMa BaoguoXiao (2016) Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson\u2019s model. Eur J Neurosci 43(1):41\u201352","journal-title":"Eur J Neurosci"},{"key":"10168_CR5","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1161\/STROKEAHA.107.489765","volume":"38","author":"T Kahles","year":"2007","unstructured":"Kahles T, Luedike P, Endres M, Galla H-J, Steinmetz H, Busse R, NeumannHaefelin T, Brandes RP (2007) NADPH oxidase plays a central role in bloodbrain barrier damage in experimental stroke. Stroke 38:3000\u20133006","journal-title":"Stroke"},{"key":"10168_CR6","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJMoa035275","volume":"349","author":"P Krack","year":"2003","unstructured":"Krack P et al (2003) Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson\u2019s disease. N Engl J Med 349:1925\u20131934","journal-title":"N Engl J Med"},{"issue":"8","key":"10168_CR7","doi-asserted-by":"publisher","first-page":"704","DOI":"10.2174\/156802609789044452","volume":"9","author":"PV Lograsso","year":"2009","unstructured":"Lograsso PV, Feng Y (2009) Rho kinase (ROCK) inhibitors and their application to inflammatory disorders. Curr Top Med Chem 9(8):704\u2013723","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"10168_CR8","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1124\/pr.115.010595","volume":"67","author":"G Loirand","year":"2015","unstructured":"Loirand G (2015) Rho Kinases in Health and Disease: From Basic Science to Translational Research. Pharmacol Rev 67(4):1074\u20131095","journal-title":"Pharmacol Rev"},{"key":"10168_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tips.2004.03.003","volume":"25","author":"W Meissner","year":"2004","unstructured":"Meissner W, Hill MP, Tison F, Gross CE, Bezard E (2004) Neuroprotective strategies for Parkinson\u2019s disease: conceptual limits of animal models and clinical trials. Trends Pharmacol Sci 25:249\u2013253","journal-title":"Trends Pharmacol Sci"},{"key":"10168_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.20338","volume":"57","author":"Y Ouchi","year":"2005","unstructured":"Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T (2005) Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease. Ann Neurol 57:168\u2013175","journal-title":"Ann Neurol"},{"key":"10168_CR11","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1172\/JCI29178","volume":"116","author":"JM Savitt","year":"2006","unstructured":"Savitt JM, Dawson VL, Dawson TM (2006) Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest 116:1744\u20131754","journal-title":"J Clin Invest"},{"issue":"1","key":"10168_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/excr.2000.5049","volume":"261","author":"AA Schmitz","year":"2000","unstructured":"Schmitz AA, Govek EE, B\u00f6ttner B, Van Aelst L (2000) Rho GTPases: signaling, migration, and invasion. Exp Cell Res. 261(1):1\u201312","journal-title":"Exp Cell Res."},{"issue":"4","key":"10168_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3109\/10409238.2013.786671","volume":"48","author":"AV Schofield","year":"2013","unstructured":"Schofield AV, Bernard O (2013) Rho-associated coiled-coil kinase (ROCK) signaling and disease. Crit Rev Biochem Mol Biol 48(4):301\u2013316","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10168_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.surneu.2006.10.037","volume":"68","author":"Y Suzuki","year":"2007","unstructured":"Suzuki Y, Shibuya M, Satoh S, Sugimoto Y, Takakura K (2007) A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage. Surg Neurol 68:126\u2013131","journal-title":"Surg Neurol"},{"key":"10168_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40478-016-0310-y","volume":"4","author":"L Tatenhorst","year":"2016","unstructured":"Tatenhorst L, Eckermann K, Dambeck V, Fonsecaornelas L, Walle H, Fonseca TLD, Koch JC, Becker S, Tonges L, Bahr M, Outeiro TF, Zweckstetter M, Lingor P (2016) Fasudil attenuates aggregation of \u03b1-synuclein in models of Parkinson\u2019s disease. Acta Neuropathol Commun 4:39","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"10168_CR16","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1007\/s10753-015-0159-4","volume":"38","author":"Lu Tong Chen","year":"2015","unstructured":"Tong Chen Lu, Xiao LZ, Ma S, Yan T, Ji H (2015) Anti-Asthmatic Effects of Ginsenoside Rb1 in a Mouse Model of Allergic Asthma Through Relegating Th1\/Th2. Inflammation 38(5):1814\u20131821","journal-title":"Inflammation"},{"key":"10168_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.nbd.2012.04.010","volume":"47","author":"B Villar-Cheda","year":"2012","unstructured":"Villar-Cheda B, Dominguez-Meijide A, Joglar B, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL (2012) Involvement of microglial RhoA\/RhoKinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors. Neurobiol Dis 47:268\u2013279","journal-title":"Neurobiol Dis"},{"key":"10168_CR18","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/S1474-4422(09)70287-X","volume":"8","author":"V Voon","year":"2009","unstructured":"Voon V et al (2009) Chronic dopaminergic stimulation in Parkinson\u2019s disease: from dyskinesias to impulse control disorders. Lancet Neurol 8:1140\u20131149","journal-title":"Lancet Neurol"},{"issue":"5","key":"10168_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nrd3430","volume":"10","author":"G Wassilios","year":"2011","unstructured":"Wassilios G, Meissner WG, Frasier M, Gasser T, Goetz CG, Lozano A, Piccini P, Obeso JA, Rascol O, Schapira A, Voon V, Weiner DM, Tison F, Bezard E (2011) Priorities in Parkinson\u2019s disease research. Nat Rev Drug Discov 10(5):377\u2013393","journal-title":"Nat Rev Drug Discov"},{"key":"10168_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1001\/jamaneurol.2013.4684","volume":"71","author":"R Watzlawick","year":"2014","unstructured":"Watzlawick R, Sena ES, Dirnagl U, Brommer B, Kopp MA, Macleod MR, Howells DW, Schwab JM (2014) Effect and reporting bias of RhoA\/ROCK-blockade intervention on locomotor recovery after spinal cord injury: a systematic review and meta-analysis. JAMA Neurol. 71:91\u201399","journal-title":"JAMA Neurol."},{"key":"10168_CR21","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","volume":"150","author":"PS Whitton","year":"2007","unstructured":"Whitton PS (2007) Inflammation as a causative factor in the aetiology of Parkinson\u2019s disease. Br J Pharmacol 150:963\u2013976","journal-title":"Br J Pharmacol"},{"issue":"8","key":"10168_CR22","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","volume":"150","author":"PS Whitton","year":"2009","unstructured":"Whitton PS (2009) Inflammation as a causative factor in the aetiology of Parkinson\u2019s disease: Inflammation and Parkinson\u2019s disease. Br J Pharmacol 150(8):963\u2013976","journal-title":"Br J Pharmacol"},{"key":"10168_CR23","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s10571-012-9845-z","volume":"32","author":"J Wu","year":"2012","unstructured":"Wu J, Li J, Hu H, Liu P, Fang Y, Wu D (2012) Rho-kinase inhibitor, fasudil, prevents neuronal apoptosis via the Akt activation and PTEN inactivation in the ischemic penumbra of rat brain. Cell Mol Neurobiol 32:1187\u20131197","journal-title":"Cell Mol Neurobiol"},{"key":"10168_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neuropharm.2015.12.007","volume":"103","author":"L Zhu","year":"2016","unstructured":"Zhu L, Chen T, Chang X, Zhou R, Luo F, Liu J, Zhang K, Wang Y, Yang Y, Long H, Liu Y (2016) Salidroside ameliorates arthritis-induced brain cognition deficits by regulating Rho\/ROCK\/NF-kB pathway. Neuropharmacology 103:134\u2013142","journal-title":"Neuropharmacology"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-024-10168-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-024-10168-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-024-10168-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T17:16:14Z","timestamp":1736874974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-024-10168-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10168"],"URL":"https:\/\/doi.org\/10.1007\/s11481-024-10168-0","relation":{},"ISSN":["1557-1904"],"issn-type":[{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"1 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"7"}}